Cox Capital Mgt LLC Abb Vie Inc. Transaction History

Cox Capital Mgt LLC

$163 Million
Q2 2024

A detailed history of Cox Capital Mgt LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cox Capital Mgt LLC holds 8,777 shares of ABBV stock, worth $1.7 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

8,777

Previous 9,542 8.02%

Holding current value

$1.7 Million

Previous $1.74 Million 13.36%

% of portfolio

0.92%

Previous 1.09%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$154.79 - $180.76 $118,414 - $138,281	-765 Reduced 8.02%	8,777 $1.51 Million
Q1 2024 Apr 10, 2024	SELL	$159.82 - $182.1 $85,024 - $96,877	-532 Reduced 5.28%	9,542 $1.74 Million
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $72,790 - $81,979	-529 Reduced 4.99%	10,074 $1.56 Million
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $109,410 - $126,658	819 Added 8.37%	10,603 $1.58 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $65,194 - $81,130	-492 Reduced 4.79%	9,784 $1.32 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $1.39 Million - $1.6 Million	-9,605 Reduced 48.31%	10,276 $1.64 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $91,699 - $109,971	663 Added 3.45%	19,881 $0
Q3 2022 Oct 11, 2022	BUY	$134.21 - $153.93 $28,318 - $32,479	211 Added 1.11%	19,218 $2.58 Million
Q2 2022 Jul 08, 2022	BUY	$137.62 - $174.96 $23,670 - $30,093	172 Added 0.91%	19,007 $2.91 Million
Q1 2022 Apr 05, 2022	SELL	$131.98 - $163.75 $527 - $655	-4 Reduced 0.02%	18,835 $3.05 Million
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $843,755 - $1.07 Million	-7,854 Reduced 29.42%	18,839 $2.55 Million
Q3 2021 Oct 06, 2021	SELL	$106.4 - $120.78 $22,237 - $25,243	-209 Reduced 0.78%	26,693 $2.88 Million
Q2 2021 Jul 02, 2021	SELL	$105.21 - $117.21 $68,491 - $76,303	-651 Reduced 2.36%	26,902 $3.03 Million
Q1 2021 Apr 01, 2021	SELL	$102.3 - $112.62 $892,056 - $982,046	-8,720 Reduced 24.04%	27,553 $2.98 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $93,126 - $125,731	1,157 Added 3.29%	36,273 $3.89 Million
Q3 2020 Oct 02, 2020	BUY	$85.91 - $100.83 $28,865 - $33,878	336 Added 0.97%	35,116 $3.08 Million
Q2 2020 Jul 01, 2020	BUY	$73.37 - $98.18 $92,739 - $124,099	1,264 Added 3.77%	34,780 $3.42 Million
Q4 2019 Jan 02, 2020	BUY	$72.13 - $90.25 $6,635 - $8,303	92 Added 0.28%	33,516 $2.97 Million
Q3 2019 Oct 01, 2019	BUY	$62.98 - $75.72 $15,493 - $18,627	246 Added 0.74%	33,424 $2.53 Million
Q2 2019 Jul 01, 2019	BUY	$65.7 - $83.98 $717,509 - $917,145	10,921 Added 49.07%	33,178 $2.41 Million
Q1 2019 Apr 03, 2019	BUY	$77.14 - $90.79 $56,312 - $66,276	730 Added 3.39%	22,257 $1.79 Million
Q4 2018 Jan 25, 2019	BUY	$77.85 - $96.01 $58,309 - $71,911	749 Added 3.6%	21,527 $1.85 Million
Q3 2018 Oct 29, 2018	BUY	$88.91 - $98.84 $50,767 - $56,437	571 Added 2.83%	20,778 $1.97 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $1.81 Million - $2.15 Million	20,207 New	20,207 $1.87 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cox Capital Mgt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cox Capital Mgt LLC with notifications on news.

Account

Cox Capital Mgt LLC Abb Vie Inc. Transaction History